NO943288D0 - Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease - Google Patents

Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease

Info

Publication number
NO943288D0
NO943288D0 NO943288A NO943288A NO943288D0 NO 943288 D0 NO943288 D0 NO 943288D0 NO 943288 A NO943288 A NO 943288A NO 943288 A NO943288 A NO 943288A NO 943288 D0 NO943288 D0 NO 943288D0
Authority
NO
Norway
Prior art keywords
pentoxyphylline
granulomatosis
preparation
treatment
pharmaceutical preparations
Prior art date
Application number
NO943288A
Other languages
Norwegian (no)
Other versions
NO943288L (en
Inventor
Peter Zabel
Ulrich Schade
Original Assignee
Rentschler Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rentschler Arzneimittel filed Critical Rentschler Arzneimittel
Publication of NO943288D0 publication Critical patent/NO943288D0/en
Publication of NO943288L publication Critical patent/NO943288L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO943288A 1993-09-21 1994-09-06 Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease NO943288L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4332041A DE4332041C2 (en) 1993-09-21 1993-09-21 Use of pentoxifylline in certain lung diseases

Publications (2)

Publication Number Publication Date
NO943288D0 true NO943288D0 (en) 1994-09-06
NO943288L NO943288L (en) 1995-03-22

Family

ID=6498198

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943288A NO943288L (en) 1993-09-21 1994-09-06 Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease

Country Status (7)

Country Link
EP (1) EP0670163A1 (en)
JP (1) JPH07247215A (en)
CZ (1) CZ230094A3 (en)
DE (1) DE4332041C2 (en)
HU (1) HUT70054A (en)
NO (1) NO943288L (en)
SK (1) SK111894A3 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
FR2779063A1 (en) * 1998-05-29 1999-12-03 Assist Publ Hopitaux De Paris PENTOXIFYLLIN COMPOSITIONS AND THEIR THERAPEUTIC USE
ECSP003747A (en) * 1999-11-02 2002-05-23 Smithkline Beecham Corp METHOD AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES
EP1297848A4 (en) * 2000-06-16 2004-05-19 Chugai Pharmaceutical Co Ltd Preventives/remedies for granuloma
US20060083714A1 (en) * 2003-01-27 2006-04-20 Warner James M Combination of a pde iv inhibitor and a tnf-alpha antagonist
WO2006035417A2 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Dihydropyrimidine microcapsule - formulations
ES2400964T3 (en) 2007-04-04 2013-04-15 Sigmoid Pharma Limited Pharmaceutical compositions of cyclosporine
CN102470106B (en) 2009-05-18 2015-09-23 希格默伊德药业有限公司 Comprise the compositions of oil droplet
IN2012DN00781A (en) 2009-08-12 2015-06-26 Sigmoid Pharma Ltd
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
KR101512223B1 (en) * 2013-02-22 2015-04-24 가톨릭대학교 산학협력단 anti-cancer adjuvant comprising pentoxifylline
ES2858517T3 (en) 2014-11-07 2021-09-30 Sublimity Therapeutics Ltd Compositions comprising cyclosporin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method

Also Published As

Publication number Publication date
EP0670163A1 (en) 1995-09-06
NO943288L (en) 1995-03-22
SK111894A3 (en) 1995-05-10
JPH07247215A (en) 1995-09-26
HU9402709D0 (en) 1995-02-28
DE4332041A1 (en) 1995-03-23
HUT70054A (en) 1995-09-28
CZ230094A3 (en) 1995-04-12
DE4332041C2 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
EE9900075A (en) 7α- (-aminoalkyl) oestratrienes, process for their preparation, pharmaceutical preparations containing 7α- (-aminoalkyl) oestratrienes and their use in the manufacture of medicaments
CZ56595A3 (en) Substituted thiazolidinedione derivatives, process of their preparation, pharmaceutical preparation in which they are comprised and their use
NO943511D0 (en) Pharmaceutical preparations and their use
MX9102110A (en) MUTEIN OF FACTOR OF HUMAN TUMOR NECROSIS OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT
NO921012L (en) PHARMACEUTICAL PREPARATIONS AND THEIR USE
NO943288D0 (en) Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease
EE9600139A (en) Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunctions
NO305903B1 (en) Benzonitriles and benzofluorides, drugs comprising the compounds, pharmaceutical compositions containing the compounds, and use of the compounds for the preparation of pharmaceutical preparations
NO307510B1 (en) Bicyclic aromatic compounds, their use and pharmaceutical and cosmetic preparations thereof
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
NO962752D0 (en) Use of 2,3-diaryl-1-benzopyran derivatives in the manufacture of a medicament for the treatment and prevention of bone loss and osteoporosis
NO304890B1 (en) Pharmaceutical compounds and pharmaceutical preparations
HUP0001526A3 (en) Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions
NO305750B1 (en) Substituted benzenesulfonylureas and their use in the preparation of pharmaceutical preparations and pharmaceutical preparations containing the compounds
NO964330D0 (en) Pharmaceutical composition for therapeutic treatment of tardive dyskinesia and use thereof
NO305792B1 (en) Substituted benzenesulfonylureas, their use in the preparation of pharmaceutical preparations and drugs containing them
NO307285B1 (en) Use of eliprodil and its enantiomers for the preparation of medical preparations
ZA951789B (en) Pharmaceutical materials and methods of administration
GB9302553D0 (en) Pharmaceutical preparations and their manufacture and use
NO952194D0 (en) Spirofuranone derivatives and their use in the treatment of neurodegenerative diseases
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances
NO911298L (en) PHARMACEUTICAL PREPARATION AND APPLICATION OF IT.
AU698359C (en) Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions
IT9048026A0 (en) PHARMACEUTICAL AND/OR COSMETIC PREPARATION.
EP0482966A3 (en) Stabilised derivatives of fragments of hirudin, their preparation and pharmaceutical preparations